Literature DB >> 17395234

Solution structure of the envelope protein domain III of dengue-4 virus.

David E Volk1, Yi-Chien Lee, Xin Li, Varatharasa Thiviyanathan, Gregory D Gromowski, Li Li, Ashley R Lamb, David W C Beasley, Alan D T Barrett, David G Gorenstein.   

Abstract

The disease dengue (DEN) is caused by four serologically related viruses termed DEN1, DEN2, DEN3 and DEN4. The structure of the ectodomain of the envelope protein has been determined previously for DEN2 and DEN3 viruses. Using NMR spectroscopic methods, we solved the solution structure of domain III (ED3), the receptor-binding domain, of the envelope protein of DEN4 virus, human strain 703-4. The structure shows that the nine amino acid changes in ED3 that separate the sylvatic and human DEN4 strains are surface exposed. Important structural differences between DEN4-rED3 and ED3 domains of DEN2, DEN3 and other flaviviruses are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395234      PMCID: PMC1950219          DOI: 10.1016/j.virol.2007.02.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Structure of West Nile virus.

Authors:  Suchetana Mukhopadhyay; Bong-Suk Kim; Paul R Chipman; Michael G Rossmann; Richard J Kuhn
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

2.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  NMR assignment of the dengue 4 virus envelope protein domain III.

Authors:  David E Volk; Yi-Chien Lee; Xin Li; Alan D T Barrett; David G Gorenstein
Journal:  J Biomol NMR       Date:  2006       Impact factor: 2.835

4.  Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.

Authors:  C W Mandl; F Guirakhoo; H Holzmann; F X Heinz; C Kunz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

Review 7.  Multidimensional heteronuclear nuclear magnetic resonance of proteins.

Authors:  G M Clore; A M Gronenborn
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

8.  An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.

Authors:  Jan-Jong Hung; Meng-Ti Hsieh; Ming-Jer Young; Chuan-Liang Kao; Chwan-Chuen King; Wen Chang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein.

Authors:  Kuen-Phon Wu; Chih-Wei Wu; Ya-Ping Tsao; Ting-Wei Kuo; Yuan-Chao Lou; Cheng-Wen Lin; Suh-Chin Wu; Jya-Wei Cheng
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

10.  Structural basis of West Nile virus neutralization by a therapeutic antibody.

Authors:  Grant E Nybakken; Theodore Oliphant; Syd Johnson; Stephen Burke; Michael S Diamond; Daved H Fremont
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

View more
  28 in total

1.  Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes.

Authors:  Lidice Bernardo; Osmel Fleitas; Alequis Pavón; Lisset Hermida; Gerardo Guillén; Maria G Guzman
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

2.  Dynamics and binding interactions of peptide inhibitors of dengue virus entry.

Authors:  Diyana Mohd Isa; Sek Peng Chin; Wei Lim Chong; Sharifuddin M Zain; Noorsaadah Abd Rahman; Vannajan Sanghiran Lee
Journal:  J Biol Phys       Date:  2019-01-24       Impact factor: 1.365

3.  Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

Authors:  Shuliu Zhang; Evgeniy I Bovshik; Rodrigo Maillard; Gregory D Gromowski; David E Volk; Catherine H Schein; Claire Y-H Huang; David G Gorenstein; James C Lee; Alan D T Barrett; David W C Beasley
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

4.  Thioaptamers targeting dengue virus type-2 envelope protein domain III.

Authors:  Sai Hari A Gandham; David E Volk; Ganesh L R Lokesh; Muniasamy Neerathilingam; David G Gorenstein
Journal:  Biochem Biophys Res Commun       Date:  2014-09-26       Impact factor: 3.575

5.  Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.

Authors:  Gregory D Gromowski; Nicholas D Barrett; Alan D T Barrett
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

6.  Structural optimization and de novo design of dengue virus entry inhibitory peptides.

Authors:  Joshua M Costin; Ekachai Jenwitheesuk; Shee-Mei Lok; Elizabeth Hunsperger; Kelly A Conrads; Krystal A Fontaine; Craig R Rees; Michael G Rossmann; Sharon Isern; Ram Samudrala; Scott F Michael
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

7.  Natural strain variation and antibody neutralization of dengue serotype 3 viruses.

Authors:  Wahala M P B Wahala; Eric F Donaldson; Ruklanthi de Alwis; Mary Ann Accavitti-Loper; Ralph S Baric; Aravinda M de Silva
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

8.  Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.

Authors:  W M P B Wahala; Annette A Kraus; Laura B Haymore; Mary Ann Accavitti-Loper; Aravinda M de Silva
Journal:  Virology       Date:  2009-07-24       Impact factor: 3.616

9.  NMR assignments of the sylvatic dengue 1 virus envelope protein domain III.

Authors:  David E Volk; Kurtis M Anderson; Sai H A Gandham; Fiona J May; Li Li; David W C Beasley; Alan D T Barrett; David G Gorenstein
Journal:  Biomol NMR Assign       Date:  2008-08-12       Impact factor: 0.746

10.  Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques.

Authors:  Germán Añez; Ruhe Men; Kenneth H Eckels; Ching-Juh Lai
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.